Category: News
Adamas Pharmaceuticals Presents Update on Nurelin Program at Cambridge Healthtech Institute’s Parkinson’s Conference
EMERYVILLE, CALIF., June 4, 2012 – Adamas Pharmaceuticals, Inc., a privately held
company, announced today that it will present an update on its NurelinTM (amantadine
- 04 06 2012
- |